ANDA 62278, held by Gruppo Lepetit. Chloramphenicol Sodium Succinate.
As of Nov 16, 2026, ANDA 62278 (Chloramphenicol Sodium Succinate), held by Gruppo Lepetit, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chloramphenicol Sodium SuccinateEQ 1GM BASE/VIAL ยท injectable;injection | Chloramphenicol Sodium Succinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters